Well, Litecoin microstrategy is also here. Funded by LTC's founders, market maker GSR served as the lead investor and advisor to transform the US stock company called MEI Pharma into a Litecoin microstrategy. In addition to the founders, GSR, and Litecoin Foundation, the institution we are familiar with Wanhui Primitive also participated in this wave of $100 million in additional stock issuance and discounted investment. Familiar conspiracies appear.